| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.88B | +11.2% |
| Cost of Revenue | $334.6M | +21.1% |
| Gross Profit | $1.55B | +9.3% |
| R&D Expense | $242.6M | +21.9% |
| SG&A Expense | $914.3M | -5.4% |
| Operating Income | $634.3M | +40.5% |
| Interest Expense | $3.4M | +76.4% |
| Pre-tax Income | $649.0M | +37.4% |
| Income Tax | $147.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $402.0M | +36.7% |
| Accounts Receivable | $39.2M | +138.4% |
| Inventory | $1.4M | +1.2% |
| Current Assets | $4.30B | +53.0% |
| Total Assets | $5.86B | +39.6% |
| Current Liabilities | $3.91B | +54.1% |
| Total Liabilities | $4.28B | +48.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $533.9M | +10.1% |
| Capital Expenditures | $192.9M | +0.2% |
| Investing Cash Flow | -$22.2M | +88.7% |
| Financing Cash Flow | $1.11B | +503.5% |
| Free Cash Flow | $341.0M | +16.6% |
| +11.7% |
| Net Income | $502.0M | +47.3% |
| EPS (Basic) | $8.93 | +51.1% |
| EPS (Diluted) | $8.92 | +51.7% |
| Stockholders' Equity |
| $1.58B |
| +20.9% |